Adaptive Biotechnologies Corp

Ownership Transactions Reported by 22 Insiders

Symbol
ADPT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
1165 Eastlake Ave E, Seattle, WA

Insiders trading volume in the past year

Adaptive Biotechnologies Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Chad M. Robins CEO and Chairman, Director $22.6M -$8M -26.1% Mar 4, 2025
Harlan S. Robins Chief Scientific Officer $9.4M -$1.19M -11.3% May 1, 2025
Julie Rubinstein President and COO $4.11M -$416K -9.18% Mar 4, 2025
Sharon Benzeno Chief Commercial Ofc Imm Med $2.75M -$312K -10.2% Mar 4, 2025
Susan Bobulsky Chief Commercial Officer, MRD $2.42M -$182K -6.97% Mar 4, 2025
Kyle Piskel Chief Financial Officer $2.4M -$108K -4.3% May 16, 2025
Francis Lo Chief People Officer $2.35M -$146K -5.85% Mar 4, 2025
Tycho Peterson Chief Financial Officer $1.83M Mar 4, 2024
Peter M. Neupert Director $1.58M -$70.5K -4.26% Mar 10, 2025
Nitin Sood Chief Commercial Officer, MRD $887K Aug 7, 2023
R. Mark Adams Chief Operating Officer $724K Apr 10, 2023
Stacy L. Taylor SVP and General Counsel $627K Aug 22, 2024
Katey Einterz Owen Director $577K Mar 4, 2025
Michael J. Pellini Director $553K Mar 4, 2025
Robert Hershberg Director $529K -$402K -43.2% Mar 12, 2025
Henning Thorsen SVP, Commercial Operations $120K May 17, 2021
Michelle Renee Griffin Director $111K -$385K -77.7% Mar 13, 2025
Leslie Trigg Director $107K Mar 6, 2023
Kevin T. Conroy Director $94.9K Mar 6, 2023
Chad M. Cohen Chief Financial Officer $89.2K Dec 22, 2021
Lance Baldo Chief Medical Officer $70.9K Mar 8, 2022
Jyoti Palaniappan SVP, Diagnostics, T-Detect $37.8K Jul 19, 2021

Recent Insider Transactions by Companies or Individuals for Adaptive Biotechnologies Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.